Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ï¿¥196,273.42, with a 24-hour trading volume of ï¿¥385.09B. The asset's market cap is ï¿¥175.26T, after moving -1.87% in the last day.
Tokenized Eli Lilly And Co is trading at ï¿¥197,330.09, with a tokenized market cap of ï¿¥7.61B and a 24-hour trading volume of ï¿¥340.91M. The tokenized asset has moved -1.95% in the past 24 hours.